methyl 5-aminolevulinate has been researched along with Cancer of Nose in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Parera, ME; Pujol, RM; Toll, A; VĂ©lez, M | 1 |
Choi, JW; Huh, CH; Jung, JY; Kim, BJ; Lee, JH; Park, KC; Yeon, JH; Youn, SW | 1 |
Cerio, R; Goldsmith, PC; Harwood, CA; McGregor, JM; Perrett, CM; Proby, CM; Tan, SK | 1 |
3 other study(ies) available for methyl 5-aminolevulinate and Cancer of Nose
Article | Year |
---|---|
Letter: photodynamic therapy with methyl aminolevulinate induces phototoxic reactions on areas of the nose adjacent to basal cell carcinomas and actinic keratoses.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Dermatitis, Phototoxic; Humans; Keratosis; Middle Aged; Nose Neoplasms; Photochemotherapy; Photosensitizing Agents | 2008 |
Keratoacanthoma aggravated after photodynamic therapy.
Topics: Aminolevulinic Acid; Disease Progression; Humans; Keratoacanthoma; Male; Middle Aged; Nose Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2010 |
Treatment of basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ-transplant recipient.
Topics: Administration, Topical; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Liver Transplantation; Middle Aged; Nose Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2006 |